Fund performance: OribMed, Claremont lead late-decade venture portfolio at UCByMark Boslet10 April 2017•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FeaturedFundraisingInvestorsManagersFeaturedFundraisingInvestor PerformancePerformance